Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorPolat, Sıla Hidayet Bozdoğan
dc.contributor.authorPolat, Abdulkadir
dc.contributor.authorUzun, Hafize
dc.contributor.authorŞahin, Gülderen
dc.contributor.authorDarıyerli, Nuran
dc.date.accessioned2024-04-04T05:59:49Z
dc.date.available2024-04-04T05:59:49Z
dc.date.issued2022en_US
dc.identifier.citationBozdoğan, S. H., Polat, A., Uzun, H., Şahin, G., & Darıyerli, N. (2022). MiRNA-129-3P Expression in Synovial Fluid of Patients with Osteoarthritis. JOURNAL OF ACADEMIC RESEARCH IN MEDICINE-JAREM, 12(1), 1-4. https://doi.org/10.4274/jarem.galenos.2021.46320en_US
dc.identifier.issn2147-1894
dc.identifier.urihttps://hdl.handle.net/20.500.12900/331
dc.description.abstractObjective: The aim of this study was to investigate the miRNA-129-3p expressions in the synovial fluid of patients with a primary knee osteoarthritis (OA), and thereby contribution to the elucidating underlying molecular mechanisms in OA pathophysiology. Methods: Patient group included 31 individuals with an advanced knee OA. A total of 13 patients with anterior cruciate ligament rupture who had no cartilage damage, were chosen as a control group. Synovial fluid samples were collected during the total knee arthroplasty and an arthroscopic reconstruction. After the centrifugation, samples were stored in a -80 °C cooler. The miRNA-129-3p expressions were examined by reverse transcriptase-polymerase chain reaction using the RNU44 molecule as a reference. The 2-ΔΔCt method was used to calculate the expression of molecules. Statistical comparisons were undertaken by the Student’s t-test. Pearson’s chi-square test was used to determine the differences in the ratios or relationships between the categorical variables. Statistical significance was set at p<0.05 for all the cases. Results: In this study, the miRNA-129-3p, which we thought to be associated with the ciliogenesis, IL-17, and osteoprotegerin, was found 1.54 times higher in the synovial fluid of the patients compared to a control group (p<0.01). Conclusion: It is thought that the miRNA-129-3p may play a role in the OA pathophysiology. Extensive studies are required to use the miRNA-129-3p as a biomarker, or a treatment target for OA.en_US
dc.language.isoengen_US
dc.publisherGALENOS PUBL HOUSEen_US
dc.relation.isversionof10.4274/jarem.galenos.2021.46320en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectKireçlenmeen_US
dc.subjectOsteoarthritisen_US
dc.subjectmiRNA-129-3pen_US
dc.subjectCiliogenezen_US
dc.subjectCiliogenesisen_US
dc.subjectSinovyal sıvıen_US
dc.subjectSynovial fluiden_US
dc.titlemiRNA-129-3P Expression in Synovial Fluid of Patients with Osteoarthritisen_US
dc.typearticleen_US
dc.departmentİstanbul Atlas Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümüen_US
dc.authoridhttps://orcid.org/0000-0002-1347-8498en_US
dc.contributor.institutionauthorUzun, Hafize
dc.identifier.volume12en_US
dc.identifier.issue1en_US
dc.identifier.startpage1en_US
dc.identifier.endpage4en_US
dc.relation.journalJOURNAL OF ACADEMIC RESEARCH IN MEDICINE-JAREMen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster